Please login to the form below

Not currently logged in
Email:
Password:

Reshma Kewalramani joins Vertex Pharmaceuticals as CMO

She will succeed Jeffrey Chodakewitz

Vertex Pharmaceuticals, a biotech known for its clinical development programmes in cystic fibrosis, has appointed a new chief medical officer in the form of Reshma Kewalramani.

She succeeds Jeffrey Chodakewitz, who will remain at the company as a senior advisor through early 2019.

Jeffrey Leiden, chairman, president and chief executive officer of Vertex, said: “Reshma’s depth of medical knowledge, paired with her experience and proven track record as a clinical leader at Vertex, makes her an ideal successor to Jeff.

“I look forward to working with her to continue to advance our clinical development pipeline in cystic fibrosis and other serious diseases.”

Prior to joining the biotech, Kewalramani served as vice president, head of the US medical organisation at Amgen, where she spent 12 years in various capacities.

She said: “It’s a privilege to work at a company with such a relentless focus on science and deep commitment to improving the lives of patients and their families.

“I am excited to assume the role of CMO and continue our important work to help more people with cystic fibrosis and other serious diseases alongside the talented team at Vertex.”

6th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics